PDF-Purpose To reduce morbidity and mortality from invasive pneumococcal disease by vaccinating

Author : faustina-dinatale | Published Date : 2014-12-13

Policy Under these standing orders eligible nurses and other healthcare professionals eg pharmacists where allowed by state law may vaccinate children who meet any

Presentation Embed Code

Download Presentation

Download Presentation The PPT/PDF document "Purpose To reduce morbidity and mortalit..." is the property of its rightful owner. Permission is granted to download and print the materials on this website for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.

Purpose To reduce morbidity and mortality from invasive pneumococcal disease by vaccinating: Transcript

Policy Under these standing orders eligible nurses and other healthcare professionals eg pharmacists where allowed by state law may vaccinate children who meet any of the criteria below Procedure 1 Identify infants and children in need of vaccinatio. Purpose: meet the criteria established by the Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices. Policy: Under these standing orders, eligible nurses and Public . health doctor . specializing . in respiratory . disease. Centers for Disease Control and Prevention . Pneumococcal Pneumonia and Pandemic H1N1. Emerging Infectious Diseases. National Center for Emerging and . Morbidity and Mortality Weekly Report Morbidity and Mortality Weekly Report Morbidity and Mortality Weekly Report U.S. Government Printing Oce: 2014-723-032/01055 Region IV ISSN: 0149-2195 Morbidity JL Castilho. , MM . Escuder. , VG . Veloso. , J . Oliveira . Gomes, K . Jayathilake. , S . Ribeiro. , R . Alencar. . Souza, ML Rodrigues Ikeda, PR de . Alencastro. ,. U . Tupinanbas. , C . Brites. By:. Dr. . Jonaidi. Associate Prof. Of infectious diseases. Hepatitis B Vaccine . Hepatitis B vaccination is recommended for all susceptible chronic hemodialysis patients. . . Vaccination is recommended for pre-end-stage renal disease patients before they become dialysis dependent, and for peritoneal and home dialysis patients because they might require in-center hemodialysis. “Patients with uremia who were vaccinated before they required dialysis have been shown to have higher . Dr. George Nelson Public health doctor specializing in respiratory disease Centers for Disease Control and Prevention Pneumococcal Pneumonia and Pandemic H1N1 Emerging Infectious Diseases National Center for Emerging and UPDATE ON PNEUMOCOCCAL DISEASE SEROTYPES: TOWARDS THE INTRODUCTION OF VACCINATION IN NIGERIA PROFESSOR G.C. ONYEMELUKWE (MON) Ahmadu Bello University Teaching Hospital, Zaria EXPERT PANEL MEETING ABUJA JUNE 16 Number needed to treat-MDA. Number needed to treat via MDA to avert 1 death. = . . = . = 526. . Keenan, NEJM, 2018. MDA . Number needed to treat-Targeted. Number needed to treat via MDA to avert 1 death. An Advisory Committee Statement ACSNational Advisory Committee on Immunization NACIUpdate on the use of 13valent pneumococcal conjugate vaccine PNEU13 in addition to 23valent pneumococcal polysacchari US Department of Health and Human Services/Centers for Disease Control and Preventionseries of publications is published by the Center for Surveillance Epidemiology and Laboratory Services Centers for and Mortality In Texas. Lisa M. Hollier, MD, MPH. Professor, Obstetrics & Gynecology. Baylor College of Medicine. Financial Disclosure. Lisa M. Hollier, MD, . has no relevant financial relationships with commercial interests to disclose. . webpage. Case ManagementIn addition to the requirements set out in the Requirement #2 of the “Management Infectious Diseases Sporadic Cases” and “Investigation and Management of Infect (Vaxigrip and Pneumo23). Dennis S. Quiambao, MD. Medical and Government Affairs Manager. |. . 2. Influenza. |. . 3. Influenza. "An unvarying disease caused by a varying virus". Kilbourne, 1980. Fiore AE, Levine OS, Elliott JA, Facklam RR, Butler JC. Effectiveness of Pneumococcal Polysaccharide Vaccine for Preschool-Age Children with Chronic Disease. Emerg Infect Dis. 1999;5(6):828-831. https://doi.org/10.3201/eid0506.990616.

Download Document

Here is the link to download the presentation.
"Purpose To reduce morbidity and mortality from invasive pneumococcal disease by vaccinating"The content belongs to its owner. You may download and print it for personal use, without modification, and keep all copyright notices. By downloading, you agree to these terms.